FindTrial
Sign In

3D Pancreatic cancer organoid models developed from EUS-FNA guided biopsy tissues for drug screening as a prospective study

3D Pancreatic cancer organoid models developed from EUS-FNA guided biopsy tissues for drug screening as a prospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17012057
Enrollment
Unknown
Registered
2017-07-20
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

2:EUS-FNA

Sponsors

Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients suspected to have pancreatic cancer who will receive EUS-FNA for diagnosis; 2) Patients who have signed the informed consent.

Exclusion criteria

Exclusion criteria: 1) Those who are under the age of 18; 2) Patients who have received adjuvant chemoradiotherapies or other anti-tumor therapies; 3) Patients with critical illness and cannot tolerate the operations; 4) Women who have been pregnant or are planning to be pregnant.

Design outcomes

Primary

MeasureTime frame
drug sensitivity;—

Countries

China

Contacts

Public ContactYing Lv

Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School

13770755008@163.com+86 13770755008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026